0001610717-24-000205.txt : 20240412
0001610717-24-000205.hdr.sgml : 20240412
20240412162340
ACCESSION NUMBER: 0001610717-24-000205
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240410
FILED AS OF DATE: 20240412
DATE AS OF CHANGE: 20240412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Sushil
CENTRAL INDEX KEY: 0001860609
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39219
FILM NUMBER: 24841795
MAIL ADDRESS:
STREET 1: C/O REPLIMUNE GROUP, INC.
STREET 2: 500 UNICORN PARK, THIRD FLOOR
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revolution Medicines, Inc.
CENTRAL INDEX KEY: 0001628171
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472029180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 415-766-3638
MAIL ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
form4.xml
X0508
4
2024-04-10
0001628171
Revolution Medicines, Inc.
RVMD
0001860609
Patel Sushil
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DR
REDWOOD CITY
CA
94063
true
true
Common Stock
2024-04-10
4
M
0
2155
16.8
A
17855
D
Common Stock
2024-04-10
4
S
0
2155
37
D
15700
D
Stock Option (Right to Buy)
16.8
2024-04-10
4
M
0
2155
0
D
2032-06-15
Common Stock
2155
34645
D
Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023.
Includes 10,450 restricted stock units.
The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 16, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
/s/ Jack Anders, as Attorney-in-fact for Sushil Patel
2024-04-12